HBV
Os inibidores do HBV são compostos projetados para atingir e inibir várias etapas do ciclo de vida do vírus da hepatite B (HBV). Esses inibidores podem interferir na replicação, montagem ou liberação viral, reduzindo assim a carga viral e ajudando a gerenciar infecções crônicas por HBV. A pesquisa sobre inibidores do HBV é crucial para o desenvolvimento de terapias antivirais eficazes para prevenir doenças hepáticas e câncer associados ao HBV. Na CymitQuimica, oferecemos uma variedade de inibidores do HBV para apoiar sua pesquisa em virologia, desenvolvimento de medicamentos antivirais e controle de doenças infecciosas.
Foram encontrados 170 produtos para "HBV".
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Bulevirtide
CAS:Bulevirtide (Myrcludex B) inhibits HBV/HDV entry into hepatocytes, treating chronic hepatitis D.Fórmula:C248H355N65O72Pureza:98%Cor e Forma:SolidPeso molecular:5398.86Tuvirumab
CAS:Tuvirumab, a human IgG1 monoclonal antibody, targets HBsAg with high affinity (K=3.6 nM) for chronic hepatitis B research.Cor e Forma:LiquidHBV/HDV-IN-4 hydrochloride
CAS:HBV/HDV-IN-4 hydrochloride (Compd 4) serves as an inhibitor of both HBV and HDV, demonstrating an EC 50 of less than 50 nM against HBV.Fórmula:C35H39BrClF3N6O7Cor e Forma:SolidPeso molecular:828.07HBV-IN-44
HBV-IN-44 (Compound (S)-2a) is an HBV inhibitor with an IC50 value of 23 nM against HbsAg. It exhibits minimal toxicity in HT22 cells and in the neurite outgrowth of ex vivo mouse DRG neurons.Fórmula:C22H26N2O5Peso molecular:398.18417HBV-IN-45
HBV-IN-45 is a selective and orally bioavailable HBV capsid assembly modulator, with an IC50 of 0.51 μM for HBcAg in HBC cells. [HBV-IN-45] demonstrates potent anti-HBV activity.Fórmula:C16H16N2O2SCor e Forma:SolidPeso molecular:300.09325Anti-virus Traditional Chinese Medicine Monomer Library
A collection of xnum TCM monomers with anti-virus activity. An effective tool for drug development and pharmacological studies.Cor e Forma:SolidRef: TM-L6730
1mgA consultar10μL*10mM (DMSO)A consultar20μL*10mM (DMSO)A consultar30μL*10mM (DMSO)A consultar50μL*10mM (DMSO)A consultar100μL*10mM (DMSO)A consultar250μL*10mM (DMSO)A consultarHBV-IN-37
CAS:HBV-IN-37, an HBV inhibitor with 10 μM EC50, may treat hepatitis B.Fórmula:C23H22ClN3O2SPureza:99.8%Cor e Forma:SolidPeso molecular:439.96(Tetrahydro-2H-pyran-4-yl)methanol
CAS:(Tetrahydro-2H-pyran-4-yl)methanol ,with CAS No. 14774-37-9, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. (Tetrahydro-2H-pyran-4-yl)methanol provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.Fórmula:C6H12O2Pureza:98.73%Cor e Forma:SolidPeso molecular:116.16HBV-IN-35
Compound HBV-IN-35 (Compound 88) serves as an HBV inhibitor and exhibits anti-HBV activity in both mouse and human hepatocytes with EC50 values of 100 nM andFórmula:C22H23F5N4OPureza:98%Cor e Forma:SolidPeso molecular:454.44Elebsiran
CAS:Elebsiran is an antiviral agent [1] .Fórmula:C485H658F9N158O294P39S6Cor e Forma:SolidPeso molecular:14976.62Destruxin B2
CAS:Destruxin B2, found in M. anisopliae, has antiviral, insecticidal properties, inhibits HBsAg (IC50=1.3 μM), and is toxic to Sf9 cells (ECIS50=92 μM).Fórmula:C29H49N5O7Cor e Forma:SolidPeso molecular:579.739PROTAC HBeAg degrader-1
PROTACHBeAg degrader-1 is a PROTAC-based targeted degrader of HBeAg. It effectively recruits the VHL E3 ligase, yet its ability to degrade the hepatitis B virus protein (HBeAg) does not depend on VHL recruitment. This compound decreases levels of both secreted and intracellular HBeAg and is suitable for research involving the hepatitis B virus (HBV).Cor e Forma:Odour SolidKR019
KR019 is a potent hepatitis B virus (HBV) capsid assembly modulator that demonstrates significant antiviral activity in HBV cells. It binds to the hydrophobic pocket at the core protein dimer-dimer interface, redirecting capsid assembly into genome-free capsids, thereby inhibiting viral replication.Cor e Forma:Odour SolidBAY38-7690
CAS:BAY38-7690, a hepatitis B virus inhibitor, may have potential for future therapeutic regimens to combat chronic HBV infection.Fórmula:C19H16ClF2N3O2Cor e Forma:SolidPeso molecular:391.8AB-161
CAS:AB-161 is an orally active destabilizer of HBV RNA and an inhibitor of PAPD5/7, primarily targeting the liver. It treats hepatitis B virus (HBV) infection by reducing hepatitis B surface antigen (HBsAg) levels, exhibiting an EC50 value of 2.2 nM for HBsAg. AB-161 is applicable in HBV infection research.Fórmula:C21H21F2N3O5Cor e Forma:SolidPeso molecular:433.41Xalnesiran sodium
CAS:Xalnesiran (sodium) is siRNA for the treatment of chronic hepatitis B ( HBV )..Fórmula:C664H814F17N231Na57O415P57S6Cor e Forma:SolidPeso molecular:22262.12Anti-Viral Compound Library
A unique collection of xnum anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening;Cor e Forma:Odour SolidRef: TM-L1700
1mgA consultar10μL*10mM (DMSO)A consultar20μL*10mM (DMSO)A consultar30μL*10mM (DMSO)A consultar50μL*10mM (DMSO)A consultar100μL*10mM (DMSO)A consultar250μL*10mM (DMSO)A consultarElebsiran sodium
Elebsiran sodium is an siRNA targeting hepatitis B and D virus infections [1].Cor e Forma:Odour SolidHBV-IN-36
HBV-IN-36 (also known as compound 42) is a hepatitis B virus (HBV) inhibitor with an IC50 of 2 μM, exhibiting anti-HBV activity characterized by an EC50 of 0.58Fórmula:C21H18ClFN4O2Pureza:98%Cor e Forma:SolidPeso molecular:412.84HBV-IN-40
HBV-IN-40 (Compound 11826096), with an IC50 of 0.7 µM, serves as a potent HBV inhibitor and exhibits antiviral activity [1].Fórmula:C29H55Cl4N11Pureza:98%Cor e Forma:SolidPeso molecular:699.63
